-
Screening & Identification of Small-molecule Pharmacophores Modulating LRRK2 Activity
… thousands of compounds that are available. Relevance to Diagnosis/Treatment of Parkinson’s Disease: If successful, our project will allow researchers to screen thousands of compounds for the ability … PD patients. In addition, the chemicals will be useful research tools to discover other human proteins that …
-
Targeting the Unfolded Protein Response (UPR) Transcription Factor XBP1 to Alleviate Neurodegeneration Triggered by Alpha-synuclein
… This grant builds upon the research from a prior grant: Targeting the Unfolded Protein … therapy to treat this important disease Relevance to Diagnosis/Treatment of Parkinson’s Disease: … Protein Response (UPR), in the development of PD. This research aims to determine whether or not the UPR is a valid …
-
Role of mGluR4 in the Modulation of Levodopa-induced Motor Performance and Dyskinesia
… (L-DOPA), the most widely prescribed treatment for PD. This research project seeks to improve the clinical utility of … in several pre-clinical models of PD. In the current research project, a collaboration between Lund University, … in a well known pre-clinical model of PD. Relevance to Diagnosis/Treatment of Parkinson’s Disease : PD is treated …
-
Generating Patient-Specific Induced Pluripotent Stem Cells to Study Parkinson's Disease
… parkin mutations, compared to normal neurons. Relevance to Diagnosis/Treatment of Parkinson’s Disease: The project … study may provide not only new targets for drug discovery research but also a unique and physiologically relevant … The results will lay the foundation for drug discovery research based on the identified targets and also allow us …
-
The Unified Dyskinesia Rating Scale (UDysRS): Clinimetric Testing Program
… Parkinson’s disease. Over the last two decades numerous research efforts have focused on understanding the regions … being tested. In concert, the care of patients and research efforts to understand dyskinesias demand the … MJFF Research Grant …
-
Neoangiogenesis and blood-brain barrier in L-DOPA-induced dyskinesia
… Neoangiogenesis and Blood-Brain Barrier in L-DOPA-induced Dyskinesia Promising Outcomes of Original Grant : Working on … correlates with the severity of the motor complications (dyskinesia) induced by levodopa. Treatments that inhibit … were found to significantly reduce the development of dyskinesia in the pre-clinical model. Objectives for …